PAION AG Aachen (PA8)

[Leff0815]

SUCCESSFUL PRODUCT LAUNCH OF ANEREM(R) (REMIMAZOLAM) IN JAPAN!

Dr. Jim Phillips, Chief Executive Officer of PAION AG, stated: "We are very pleased to hear that after the recent launch in Japan our partner has now made their first commercial sales, and product listing in multiple University & General Hospitals. PAION is eligible to royalties between 16-18% in Japan. This news is the first demonstration of a positive market response to the launch of remimazolam, and we look forward to sharing further commercial news when we receive it regarding the Japanese market."

link